Optiscan Imaging Limited

OIL

AU000000OIL4

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. Other stock markets 06:38:08 14/06/2024 BST			5-day change	1st Jan Change
0.15 ^AUD	-3.23%		0.00%	+78.57%

06-04	Optiscan Imaging Introduces InVue Imaging Device	MT
05-13	Optiscan Imaging Limited Signs Know-How Agreement with Mayo Clinic	CI

OptiScan Imaging Limited Receives Orders from Carl Zeiss Meditec AG

January 12, 2021 at 10:40 pm

OptiScan Imaging Limited advised that it has received orders from Carl Zeiss Meditec AG pursuant to its Co-operation Agreement for approximately AUD 350,000.

Latest news about Optiscan Imaging Limited

Optiscan Imaging Introduces InVue Imaging Device	06-04	MT
Optiscan Imaging Limited Signs Know-How Agreement with Mayo Clinic	05-13	CI
Optiscan Imaging CEO to Host Mayo Clinic Agreement Webinar	05-13	MT
Optiscan Imaging Receives More Than AU$670,000 as R&D Tax Rebate	03-21	MT
Optiscan Imaging Limited Reports Earnings Results for the Half Year Ended December 31, 2023	02-22	CI
Optiscan Imaging Secures AU$3 Million Research Grant for Endomicroscope Device; Shares Rise 8%	02-13	MT
Optiscan Imaging Appoints COO	23/10/23	MT
Optiscan Imaging Limited Appoints Brendan Fafiani to the Role of Chief Operating Officer, Effective 6 November 2023	23/10/23	CI
Cancer Images from Optiscan's Platform Comparable With Conventional Histology Analysis, Study Says	20/09/23	MT
Optiscan Imaging Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/08/23	CI
Optiscan Imaging Completes Key Milestone for Telepathology Project	15/08/23	MT
Optiscan Imaging Establishes New Commercial Operation in the US	03/04/23	MT
Optiscan Imaging Confirms High Diagnostic Rate of Imaging Device	14/03/23	MT
Optiscan Imaging Receives US FDA Feedback for Oral Imaging Product	02/03/23	MT
Optiscan Imaging Limited Intends to Pursue De Novo Pathway for InVivage	02/03/23	CI
Optiscan Imaging Limited Reports Earnings Results for the Half Year Ended December 31, 2022	27/02/23	CI
Optiscan Imaging Limited Announces Partnership with Prolucid Technologies to Develop AI Algorithms	29/01/23	CI
Optiscan Imaging Proposes Issuance of 6 Million Securities	25/10/22	MT
Optiscan Imaging Acquiring Clinical Datasets from Managing Director; Shares Rise 4%	25/10/22	MT
Optiscan Imaging Secures R&D Tax Rebate	24/10/22	MT
Optiscan Imaging Limited Reports Earnings Results for the Full Year Ended June 30, 2022	31/08/22	CI
Optiscan Imaging Files US FDA Application for Oral Tissue Imaging Device	22/08/22	MT
Optiscan Submits FDA 510(k) Application for InVivage Device	22/08/22	CI
Optiscan Imaging Limited Announces Strategic Distribution Partnership - Additional Information	28/06/22	CI
Optiscan Imaging Appoints China Distributor for Research, Preclinical Device	27/06/22	MT

Chart Optiscan Imaging Limited

Duration

Period

More charts

Optiscan Imaging Limited is an Australia-based company, which is engaged in the development, manufacturing and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The Companyâs technology enables real-time, non-destructive, three-dimensional (3D), in-vivo imaging at the single-cell level. It provides real-time microscopic imaging tools to healthcare providers and researchers to enable the early detection and management of disease. Its InVivage device is an intra-oral digital microscope that offers the power of single-cell oral imaging at your fingertips in the palm of your hand. Its ViewnVivo offers single-cell level live imaging, providing biological system insights and enabling users to see life connected. Developed with its patented confocal imaging technology, ViewnVivo is a miniaturized in vivo imaging device that offers single-cell 3D live microscopic imaging in the palm of your hand.

Sector

Advanced Medical Equipment & Technology

Calendar

28/08/2024 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
OPTISCAN IMAGING LIMITED	+78.57%	82.85M
THERMO FISHER SCIENTIFIC	+7.77%	218B
DANAHER CORPORATION	+10.16%	189B
INTUITIVE SURGICAL, INC.	+26.21%	151B
BOSTON SCIENTIFIC CORPORATION	+32.78%	113B
SIEMENS HEALTHINEERS AG	+1.98%	64.02B
EDWARDS LIFESCIENCES CORPORATION	+14.48%	52.6B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+2.92%	49.85B
AGILENT TECHNOLOGIES, INC.	-6.60%	37.89B
GE HEALTHCARE TECHNOLOGIES INC.	-1.07%	34.92B

Other Advanced Medical Equipment & Technology